US 10,864,352 B2 · Systems, devices and methods for the creation of a therapeutic restriction in the gastrointestinal tract

Abstract

A system for treating a patient comprises a delivery device and injectate. The delivery device comprises an elongate shaft with a distal portion and at least one delivery element positioned on the elongate shaft distal portion. The delivery device is constructed and arranged to deliver the injectate through the at least one delivery element and into tissue to create a therapeutic restriction in the gastrointestinal tract. Methods of creating a therapeutic restriction are also provided.

Claims37

Dependent claims

A method of reducing a patient's weight, said method comprising:

advancing a fluid delivery element to a location proximate a luminal segment of the gastrointestinal tract of the patient;
and
delivering an injectate through the delivery element and into tissue proximate the luminal segment to create a therapeutic restriction in the luminal segment;
wherein the luminal segment is located in the patient's proximal or distal small intestine;
wherein the patient experiences a loss of weight in response to the therapeutic restriction.

2 more elements

Dependencies are inferred from the claim text.

Facts

Application

16/267,771Filed 5 Feb 2019 · continuation

Priority

22 Nov 2013

Published

US 2020/0001047 A12 Jan 2020

Granted

15 Dec 2020

Term ends

Not estimatedThe source records don’t support an estimate.

Classification25 codes

A61M 25/0084
Catheter tip comprising a tool: being one or more injection needles
A61F 5/0013
Apparatus for the treatment of obesity; Anti-eating devices: implantable devices or invasive measures
A61F 5/0076
Implantable devices or invasive measures: preventing normal digestion, e.g. Bariatric or gastric sleeves
A61K 31/728
Glycosaminoglycans, i.e. mucopolysaccharides: hyaluronic acid

Family

Application61/907,808Us provisional application · filed 22 Nov 2013

PCT/US2014/066829Parent of this continuation · filed 21 Nov 2014

Application15/156,585Parent of this continuation · filed 17 May 2016

US 2020/0001047 A1Pre-grant publication · published 2 Jan 2020

US 10,232,143 B2Parent of this continuation

US 2016/0256663 A1Published application

US 10,864,352 B2This patent

From the US filing history. Foreign family members aren’t listed.

Systems, devices and methods for the creation of a therapeutic restriction in the gastrointestinal tract

Life of this patent

Systems, devices and methods for the creation of a therapeutic restriction in the gastrointestinal tract

Life of this patent

Abstract

Claims37